About Pre-B-cell leukemia transcription factor 2
Pre-B-cell leukemia transcription factor 2 (PBX2) is a protein
from Homo sapiens identified by UniProt accession
P40425, 430 residues long.
MolForge cross-references it against 0 known binders and
27 disease associations.
Target properties
| Protein name | Pre-B-cell leukemia transcription factor 2 |
| UniProt accession | P40425 |
| Gene | PBX2 |
| Organism | Homo sapiens |
| Length | 430 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (27)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.30
- Parkinson disease · score 0.28
- multiple sclerosis · score 0.28
- Alzheimer disease · score 0.28
- lysosomal storage disease · score 0.28
- wet macular degeneration · score 0.16
- atrophic macular degeneration · score 0.16
- age-related macular degeneration · score 0.16
- blood protein measurement · score 0.16
- coronary artery disease · score 0.15
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P40425-F1 | alphafold | PREDICTED | 69.03 | — |
Amino-acid sequence (430 residues)
MDERLLGPPP PGGGRGGLGL VSGEPGGPGE PPGGGDPGGG SGGVPGGRGK QDIGDILQQI MTITDQSLDE AQAKKHALNC HRMKPALFSV LCEIKEKTGL SIRSSQEEEP VDPQLMRLDN MLLAEGVAGP EKGGGSAAAA AAAAASGGGV SPDNSIEHSD YRSKLAQIRH IYHSELEKYE QACNEFTTHV MNLLREQSRT RPVAPKEMER MVSIIHRKFS AIQMQLKQST CEAVMILRSR FLDARRKRRN FSKQATEVLN EYFYSHLSNP YPSEEAKEEL AKKCGITVSQ VSNWFGNKRI RYKKNIGKFQ EEANIYAVKT AVSVTQGGHS RTSSPTPPSS AGSGGSFNLS GSGDMFLGMP GLNGDSYSAS QVESLRHSMG PGGYGDNLGG GQMYSPREMR ANGSWQEAVT PSSVTSPTEG PGSVHSDTSN
Explore Pre-B-cell leukemia transcription factor 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets